QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (15) Citing Articles via Google Scholar Google Scholar Articles by Yurek, D. M. Articles by Altar, C. A. Search for Related Content PubMed PubMed Citation Articles by Yurek, D. M. Articles by Altar, C. A.

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 1, 1998, 18(15):6040-6047

Optimal Effectiveness of BDNF for Fetal Nigral Transplants Coincides with the Ontogenic Appearance of BDNF in the Striatum

David M. Yurek¹, Susan B. Hipkens¹, Stanley J. Wiegand², and C. Anthony Altar²

¹ Department of Surgery/Neurosurgery and Anatomy and Neurobiology, University of Kentucky College of Medicine, Lexington, Kentucky 40536, and ² Regeneron Pharmaceuticals, Inc., Tarrytown, New York 10591

Transplantation of fetal nigral dopamine neurons into the caudate and putamen of Parkinson's disease patients produces limited symptomatic relief. One approach to augment the outgrowth and function of nigral grafts includes exposure of the graphs to neurotrophic factors; however, the temporal requirements for optimizing these actions are unknown. The present study characterized the ontogeny of brain-derived neurotrophic factor (BDNF) in the rat striatum and used this information to define and evaluate three distinct periods of BDNF infusion into fetal nigral grafts transplanted into the striatum of rats with experimental Parkinson's disease. At postnatal day 1 (P1), BDNF and dopamine were measured at 17 and 27% of peak levels, respectively, that occurred at P27 for both. Both compounds showed their greatest surge between P7 and P20, increasing from 40% to ~95% of peak levels. Exogenous BDNF infused into transplants during weeks 1 and 2 after the transplantation, which coincide with the developmental period embryonic day 14 (E14)-P7 for transplanted tissue, did not improve rotational behavior or enhance fiber outgrowth of transplanted dopamine neurons. Delaying the BDNF infusion until transplanted tissue was approximately P8-P21 greatly enhanced the effect on rotational behavior and doubled the area of dopamine fiber outgrowth from the transplants. Delaying the infusion until transplanted tissue was approximately P36-P49 failed to augment fiber outgrowth and decreased the behavioral function of transplants. Thus, the optimal effect of exogenous BDNF on the development of dopamine neurons in fetal nigral transplants occurs at a postnatal age when endogenous dopamine and BDNF show the greatest increases during the normal development of the striatum.

Key words: brain-derived neurotrophic factor; development; dopamine; Parkinson's disease; neural transplantation; neurotrophic factor; fiber outgrowth

---

Copyright © 1998 Society for Neuroscience  0270-6474/98/18156040-08$05.00/0

This article has been cited by other articles:

				M. Niculescu, S. A. Perrine, J. S. Miller, M. E. Ehrlich, and E. M. Unterwald Trk: A Neuromodulator of Age-Specific Behavioral and Neurochemical Responses to Cocaine in Mice J. Neurosci., January 30, 2008; 28(5): 1198 - 1207. [Abstract] [Full Text] [PDF]

				Y. Yin, G. M. Edelman, and P. W. Vanderklish The brain-derived neurotrophic factor enhances synthesis of Arc in synaptoneurosomes PNAS, February 19, 2002; 99(4): 2368 - 2373. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help